[go: up one dir, main page]

DK189982A - Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler - Google Patents

Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler Download PDF

Info

Publication number
DK189982A
DK189982A DK189982A DK189982A DK189982A DK 189982 A DK189982 A DK 189982A DK 189982 A DK189982 A DK 189982A DK 189982 A DK189982 A DK 189982A DK 189982 A DK189982 A DK 189982A
Authority
DK
Denmark
Prior art keywords
octasaccharides
abreviation
preparation
see diagramm
denoted below
Prior art date
Application number
DK189982A
Other languages
English (en)
Inventor
J C Lormeau
J Choay
M Petitou
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay Sa filed Critical Choay Sa
Publication of DK189982A publication Critical patent/DK189982A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02007—Heparin lyase (4.2.2.7), i.e. heparinase I

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK189982A 1981-04-29 1982-04-28 Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler DK189982A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8108604A FR2504928A1 (fr) 1981-04-29 1981-04-29 Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments

Publications (1)

Publication Number Publication Date
DK189982A true DK189982A (da) 1982-10-30

Family

ID=9257922

Family Applications (1)

Application Number Title Priority Date Filing Date
DK189982A DK189982A (da) 1981-04-29 1982-04-28 Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler

Country Status (9)

Country Link
EP (1) EP0064452B1 (da)
JP (1) JPS57190001A (da)
AT (1) ATE12791T1 (da)
CA (1) CA1180292A (da)
DE (1) DE3263083D1 (da)
DK (1) DK189982A (da)
ES (1) ES8302094A1 (da)
FR (1) FR2504928A1 (da)
IE (1) IE52906B1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
US5106734A (en) * 1986-04-30 1992-04-21 Novo Nordisk A/S Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
EP0861903A1 (en) * 1997-02-22 1998-09-02 Lansing, Manfred Method for reversible immobilizing oligo and/or polysaccharides
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
RU2538973C2 (ru) 2008-05-30 2015-01-10 Момента Фармасьютикалз, Инк. Структуры сахаридов и способы получения и применения таких структур
WO2017113197A1 (zh) * 2015-12-30 2017-07-06 深圳市海普瑞药业集团股份有限公司 硫酸化肝素寡糖及其制备方法和应用
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
MX2022000343A (es) 2019-07-09 2022-03-11 Optimvia Llc Metodos para sintetizar polisacaridos anticoagulantes.
JP7611465B2 (ja) * 2019-10-10 2025-01-10 ジェイ・アイ・サイエンス有限会社 溶離液性の利用フラクションコレクター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
JPH0231721A (ja) * 1988-07-20 1990-02-01 Matsushita Electric Ind Co Ltd 充電式掃除機

Also Published As

Publication number Publication date
IE820741L (en) 1982-10-29
ES511470A0 (es) 1983-02-01
ES8302094A1 (es) 1983-02-01
JPS57190001A (en) 1982-11-22
FR2504928A1 (fr) 1982-11-05
CA1180292A (en) 1985-01-02
FR2504928B1 (da) 1984-02-24
IE52906B1 (en) 1988-04-13
ATE12791T1 (de) 1985-05-15
DE3263083D1 (en) 1985-05-23
EP0064452A1 (fr) 1982-11-10
EP0064452B1 (fr) 1985-04-17

Similar Documents

Publication Publication Date Title
DK189982A (da) Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler
AU627207B2 (en) Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent
US3829567A (en) Alkali metal salts of nucleotides useful as medicines for the fibronilityc system
ES2044829T1 (es) Una composicion para el tratamiento in vivo de da\os en los tejidos producidos por isquemia u otra disfuncion proveniente de oxidacion.
ES312813A1 (es) Procedimiento para la produccion de nuevos derivados de imidazol (2, 1, b) tiazol
BR9811779A (pt) Tetrahidro prostaglandina s substituìdas por c16-c20 aromáticos úteis como agonistas fp
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BR0111126A (pt) Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
BR0008778A (pt) Análogos de prostaglandinas seletivos para fpc16 insaturados
BR0008776A (pt) Análogos de prostaglandinas fp-seletivosinsaturados c16
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
AU6076886A (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
BR0109328A (pt) Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
ES2034184T3 (es) Esterilizacion de composiciones de estabilidad limitada.
ES2149403T3 (es) Benciloxicarbonilguanidinas sustituidas como inhibidores del intercambiador de protones de sodio, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
NO20011091L (no) Umettede hydroksiminsyrederivater som PARP inhibitorer
BR0109617A (pt) Composição farmacêutica, oligossacarìdeo, processo de preparação de oligossacarìdeos, e, utilização de oligossacarìdeos
BR9909268A (pt) C11 oximil e hidroxilamino prostaglandinas úteis como agonistas de fp
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
ATE7202T1 (de) Nichtadsorbierbare, mukolytische verbindungen, verfahren zu ihrer herstellung und therapeutische zusammensetzungen, die diese verbindungen als wirkstoff enthalten.
JPH06248267A (ja) 新規抗酸化剤
Moosa Peripheral neuropathy in Leigh's encephalomyelopathy
DK291786D0 (da) Neuroleptisk aktivt, farmaceutisk praeparat og fremgangsmaade til dets fremstilling
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment